Allele-specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 21, Issue 11, 2001, Pages 1834-1839

  Jormsjö, Sofia ^a   Whatling, Carl ^a   Walter, Dirk H ^a   Zeiher, Andreas M ^a   Hamsten, Anders ^a   Eriksson, Per ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Gene regulation; LDL; Matrilysin; Matrix metalloproteinase 7; Polymorphisms

Indexed keywords

LOW DENSITY LIPOPROTEIN; MATRILYSIN;

AMINO ACID SUBSTITUTION; ANEURYSM; ARTICLE; ATHEROSCLEROSIS; CELL STRAIN U937; CORONARY ARTERY; GENE CONTROL; HUMAN; HYPERCHOLESTEROLEMIA; MACROPHAGE; MAJOR CLINICAL STUDY; NORTHERN BLOTTING; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0035571592     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/hq1101.098229     Document Type: Article

References (23)

1. Matrix metalloproteinases and cardiovascular disease
2. Pump-1 cDNA codes for a protein with characteristics similar to those of classical collagenase family members
3. Purification and characterization of extracellular matrix-degrading metalloproteinase, martin (pump-1), secreted from human rectal carcinoma cell line
4. Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme
5. Role of matrix metalloproteinases in abdominal aortic aneurysms
6. Genetic diversity in the matrix metalloproteinase family: Effects on function and disease progression
7. Allele-specific regulation of matrix metalloproteinase-12 gene activity is associated with coronary artery luminal dimensions in diabetic patients with manifest coronary artery disease
8. Very-low-density lipoprotein response element in the promoter region of the human plasminogen activator inhibitor-1 gene implicated in the impaired fibrinolysis of hypertriglyceridemia
9. Effects of native, triglyceride-enriched, and oxidatively modified LDL on plasminogen activator inhibitor-1 expression in human endothelial cells
10. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction
11. Relation of plasma levels and composition of apolipoprotein B-containing lipoproteins to angiographically defined coronary artery disease in young patients with myocardial infarction
12. Platelet glycoprotein IIIa polymorphisms and risk of coronary stent thrombosis
13. Mouse heat shock transcription factors 1 and 2 prefer a trimeric binding site but interact differently with the HSP70 heat shock element
14. One cell-specific and three ubiquitous nuclear proteins bind in vitro to overlapping motifs in the domain B1 of the SV40 enhancer
15. Lysophosphatidylcholine: A chemotactic factor for human monocytes and its potential role in atherogenesis
16. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells
17. Enhancement of monocyte adhesion to endothelial cells by oxidatively modified low-density lipoprotein is mediated by activation of CD11b
18. In vitro effects of oxidized low density lipoprotein on CD11b/CD18 and L-selectin presentation on neutrophils and monocytes with relevance for the in vivo situation
19. Effect of the stromelysin-1 promoter on efficacy of pravastatin in coronary atherosclerosis and restenosis
20. Arterial remodeling at the reference site after angioplasty in the atherosclerotic rabbit model
21. Morphological changes during follow-up after successful percutaneous transluminal coronary balloon angioplasty: Quantitative angiographic analysis in 778 lesions-further evidence for the restenosis paradox
22. Coronary vascular remodeling in association with endothelial dysfunction